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Limited degrees of summation and inhibition [by up to 15%) in the 
human heart have been described previously. using bipolar 
conditioning stimuli of conventional (2ms) pulse width delivered 
during the refractory period. 
We have used long duration constant current subthreshold 
conditioning stimuli (SC) in 32 pts undergoing clinical 
electrophysiological studies. Continuous atrial or ventricular pacing 
(SlSl = 500 or 600msl was performed throughout the study to 
stablllse refractory periods. Effective refractory period (ERP) was 
determined with a 2ms pulse (S2) at an amplitude of twice the late 
diastolic threshold. A lorf duration conr:itioning pulse (duration = 
S1S2)wastheninlroducea. 
Bipolar stimuli were used in 8 pts, and lnllibition was produced in all. 
the effective refkactosy period (ElW) being lengthened by 97%. from 
238i44 ms to 469+103 ms. SC polarity was reversed in 6 pls; the ERP 
was shortened in 4 pts (from 2 19&25 to 183.&S ms), lengthened in one. 
and unchanged in one. 
Unipolar stimuli were used in a further 24 pts. al SC produced 
inhibItion In all 24 pts. prolonging ERP by 97 24 1~37 ms to 
474+91 ms. I SC shortened the EW (from 230~37 ms to 165234 
ms) in 12 pts and lengthened the EW &cm 233233 ms to 3859304 
msl in 11 pts. 
~~~~~~n~: lnhlbition and summation may be produced in the same 
patient by reversal of SC polarity. Cathodal current always produces 
inhlbltion: summation, when it occurs. is produced by anodal current. 
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To evaluate the potential for quinidine (QUIN) 
therapy to increase mortality a 
arrhythmia (PROA) in patients ( S) with benign 
or potentially lethal ventricul 
(WA), we performed a meta-analysis on 3 double 
blind randomized placebo controlled parallel 
trials in 904 PTS in which QUIN 
flecainide (FLEC), mexiletine ( X) anal tocain- 
ide (TOC). All 3 trials had similar protocols 
and methodology (e.g. Helter monitoring) but 
varying lengths of drug exposure. The analysis 
was performed using the Mantel-Haenszel method 
on the following data: 
QUIN-MEX WIN-FLEC QUIN-TOC 
# PTS 245 246 139 141 66 67 
Deaths 7 2 3 1 11 
PROA 18 0 2 0 0 0 
The combined relative risk of dying on QUIN 
versus the other 3 drugs was 2.77 (C.I.=O.93, 
8.24). There were no deaths OS-I placebo (2 wks 
exposure for 624 and 1 wk for 280 PTS); on the 4 
active drugs there were 7 deaths within 2 wks, 6 
on QUIN and 1 on MEX. PROA occurred in 20 PTS 
on QUIN vs 10 PTS on the 3 other drugs for a 
combined relative risk of PROA on QUIN of 1.88 
(C.I.=1.03, 3.43). These data show that QUIN 
may have at least as much an effect on PROA and 
mortality as Class IC (FLEC) and possihly IB 
(MEX, TOC) drugs in the treatment of VEA. 
0ETECTION OF PATlERiTS WITH BUNDLE BRAkCH BLOCK AT RISK 
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Although it sas reported that fast-Pou 
analysis(FFTA) of signal-averaged ECGs 
tection of pts with ventricular tacbyca 
the presence of bundle branch block (B) in pts with is- 
ic heart disease, clinical significance of FFTA of 
al-averaged ECGs re ain unclear in pts with nonis- 
signal-averaged Y lead and the power spectru 
obtained. Area ratio calculated by dividing the area 
agnitude ratio were cal- 
of the entire signal. 
Area ratio : 0.535+0.220 0.298_+ 0.010 p<o. 05 
agnitude ratio: Q.383-+0.101 O.ttiO+o.U83 p<o. 05 
concluded that the 
veraged Y lead 
ght contain a 
suggest that FFTA of signal- 
averaged ECGs could be useful for detection of pts rith 
nonischemic. undocumented VT despite the presence of B. 
MIGH FREQUENCY OF LATE POTENTIALS IN MITRAL VALVE PROLAPSE 
Gioia Turitto% Demo Klonis, Jesus E. Val-Mejias, 
Wichita Institute for Clinical Research, Wichita, KS 
This study included 35 pts (22 females, 13 males, age 
55*19 years) with mitral valve prolapse @VP), absent or 
mild valve regurgitatior, I?O bundle branch block, normal 
LV function and wall motion. They all IJ.~ x-went 24-hour 
ambulatory ECG and signal averaged ECG (SAECG, high-pass 
filter 25 or 40 Hz). A stress test was performed in 24 
cases. In 28 pts with age?30 years, significant coronary 
disease was ruled out by angiography in 16, by thallium 
stress scintigrapi,y in 5, and by both tests in 7. During 
ambulatory ECG, 13 pts (37Z) had frequent ventricular 
premature complexes blO/hour), 5 (14X) had non-sustained 
ventricular tachycardia (VT), 5 (14%) had both. VT was 
documented during stress test only in 6 pts and was 
sustained in 2. The SAECG was abnormal in 12 pts (34I)at 
25 Hz: 9 had late potentials [LPs, low amplitude signal 
duration (LAS)>32 ms and RMS voltage of last 40 ms of QRS 
(RMS40)625 &IV]* 3 had both LPs and prolonged QRS duration 
(7115 ms). At 40 Hz, the SAECG was abnormal in 9 Pts 
(26%): 7 had LPs (LAS739 ms and RMS4Oe:16 yv), 2 had both 
LPs and prolonged QRS duration (>I11 ms). The frequency 
of an abnormal SAECG at 25 or 40 Hz was not significantly 
different in cases with or without spontaneous VT . 
Programmed electrical stimulation was performed in 9 pts 
who had syncope or sustained VT: ventricular fibrillation 
was induced in 2 cases (1 with LPs), no sustained VT/ 
fibrillation in 7 (3 with LPs). Thus, in MVP: 1) 
spontaneous VT is common, while induced VT is rare; 2) 
there is no correlation between an abnormal SAECG and 
spontaneous or induced VT; 3) the high frequency of LPs 
may represent another feature of the “MVP syndrome”; its 
prognostic significance is uncertain but probably benign. 
